This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
clinical signs | 1183 |
mg kg | 674 |
bone marrow | 515 |
lymph nodes | 316 |
liver disease | 248 |
healthy dogs | 247 |
may also | 237 |
canine distemper | 234 |
mg dl | 192 |
chronic hepatitis | 182 |
physical examination | 180 |
blood pressure | 174 |
weight loss | 164 |
body weight | 164 |
may occur | 162 |
lymph node | 161 |
kg iv | 158 |
ml kg | 155 |
present study | 155 |
red blood | 148 |
veterinary medicine | 147 |
respiratory disease | 147 |
raccoon dogs | 140 |
distemper virus | 139 |
significantly higher | 139 |
united states | 134 |
one dog | 130 |
whole blood | 130 |
retrospective study | 130 |
affected dogs | 128 |
blood cell | 128 |
heart failure | 128 |
spinal cord | 127 |
small animal | 124 |
cell lymphoma | 124 |
blood cells | 123 |
blood samples | 123 |
differential diagnosis | 123 |
peripheral blood | 123 |
heart rate | 122 |
raccoon dog | 121 |
cell tumors | 120 |
significant difference | 117 |
hemolytic anemia | 117 |
portal vein | 116 |
two dogs | 115 |
portal hypertension | 113 |
domestic dogs | 112 |
infected dogs | 111 |
definitive diagnosis | 110 |
canine parvovirus | 105 |
kg po | 104 |
infectious diseases | 104 |
median age | 102 |
mg ml | 101 |
mast cell | 99 |
may result | 99 |
risk factors | 98 |
gastrointestinal tract | 98 |
may cause | 97 |
ng ml | 97 |
naturally occurring | 94 |
cerebrospinal fluid | 94 |
nervous system | 94 |
young dogs | 93 |
significant differences | 92 |
chain reaction | 91 |
polymerase chain | 91 |
survival time | 91 |
one study | 90 |
aqueous humor | 88 |
canine herpesvirus | 88 |
statistically significant | 88 |
liver biopsy | 88 |
mucous membranes | 87 |
blood flow | 87 |
diabetes mellitus | 87 |
multiple myeloma | 87 |
interest reported | 86 |
mitral valve | 86 |
renal failure | 85 |
respiratory distress | 85 |
neoplastic cells | 84 |
bile acids | 84 |
normal dogs | 84 |
canine rabies | 83 |
red pulp | 83 |
pulmonary edema | 82 |
medical records | 82 |
hepatic copper | 82 |
magnetic resonance | 81 |
breed dogs | 81 |
bile duct | 81 |
general anesthesia | 80 |
orogastric lavage | 80 |
computed tomography | 80 |
companion animals | 80 |
determine whether | 80 |
activated charcoal | 79 |
immune response | 79 |
portosystemic shunts | 78 |
significantly lower | 78 |
blood glucose | 78 |
fecal samples | 77 |
hepatic disease | 76 |
urinary tract | 76 |
see chapter | 75 |
african wild | 75 |
mm hg | 75 |
abdominal ultrasound | 75 |
infectious agents | 75 |
plasma cell | 75 |
foreign bodies | 74 |
three dogs | 74 |
domestic animals | 73 |
control dogs | 73 |
congestive heart | 73 |
increased serum | 72 |
may include | 72 |
mean age | 72 |
complete blood | 72 |
adult dogs | 72 |
significantly different | 71 |
pleural effusion | 71 |
control group | 71 |
serum samples | 71 |
may develop | 70 |
see section | 70 |
performed using | 70 |
body condition | 70 |
dogs may | 70 |
central nervous | 70 |
introduction purpose | 70 |
median survival | 70 |
dog population | 70 |
left ventricular | 69 |
one cat | 69 |
resonance imaging | 69 |
plasma cells | 68 |
chv infection | 68 |
intravenous fluids | 68 |
differential diagnoses | 68 |
respiratory tract | 68 |
portosystemic shunting | 67 |
increased risk | 67 |
animal health | 67 |
hepatobiliary disease | 67 |
abdominal pain | 67 |
anterior chamber | 66 |
gene expression | 65 |
disseminated intravascular | 65 |
discussion conclusion | 65 |
intravascular coagulation | 65 |
statistical analysis | 64 |
renal disease | 64 |
cord uid | 64 |
doc id | 64 |
needle aspiration | 64 |
wild dogs | 64 |
commercially available | 63 |
canine adenovirus | 62 |
inflammatory response | 62 |
hepatic encephalopathy | 62 |
healthy cats | 62 |
left atrial | 62 |
biliary tract | 62 |
side effects | 61 |
human patients | 61 |
alt activity | 61 |
dog bite | 61 |
protein concentration | 60 |
thoracic radiographs | 60 |
supplemental oxygen | 60 |
commonly used | 60 |
canine infectious | 60 |
every hours | 59 |
epithelial cells | 59 |
kidney disease | 59 |
foreign body | 59 |
naturally infected | 59 |
bowel disease | 58 |
upper respiratory | 58 |
hepatic necrosis | 58 |
soft tissue | 57 |
many cases | 57 |
bordetella bronchiseptica | 57 |
arterial blood | 57 |
within hours | 57 |
disease process | 57 |
time pcr | 57 |
public health | 57 |
immune system | 57 |
affected animals | 56 |
oxidative stress | 56 |
blood vessels | 56 |
heart disease | 56 |
urinary bladder | 56 |
canine lymphoma | 56 |
clinical presentation | 55 |
liver enzyme | 55 |
inflammatory bowel | 55 |
pathologic findings | 55 |
canine coronavirus | 55 |
body temperature | 55 |
male dogs | 55 |
fluid therapy | 55 |
owned dogs | 55 |
neurological signs | 55 |
doberman pinschers | 54 |
signs associated | 54 |
clinical disease | 54 |
liver injury | 54 |
viral infections | 54 |
immunodeficiency virus | 54 |
signs may | 54 |
bite injuries | 53 |
blood count | 53 |
feline infectious | 53 |
valve disease | 53 |
dogs treated | 53 |
reference interval | 53 |
least one | 53 |
results suggest | 53 |
lycaon pictus | 52 |
hepatic injury | 52 |
bile ducts | 52 |
frozen plasma | 52 |
also occur | 51 |
congenital pss | 51 |
underlying cause | 51 |
gastrointestinal disease | 51 |
small animals | 51 |
german shepherd | 51 |
fresh frozen | 51 |
new york | 51 |
research complications | 50 |
amino acid | 50 |
renal function | 50 |
canine respiratory | 50 |
skin lesions | 50 |
infectious peritonitis | 50 |
inclusion criteria | 49 |
growth factor | 49 |
dog owners | 49 |
serum cobalamin | 49 |
survival times | 49 |
marginal zone | 49 |
liver diseases | 49 |
neurologic signs | 49 |
small intestine | 49 |
infectious disease | 49 |
whenever possible | 49 |
endothelial cells | 49 |
may require | 48 |
labrador retrievers | 48 |
contrast material | 48 |
antibiotic therapy | 48 |
human medicine | 48 |
kg day | 48 |
adverse effects | 47 |
domestic dog | 47 |
bedlington terriers | 47 |
cutaneous lymphoma | 47 |
beagle dogs | 47 |
highland white | 47 |
nasal discharge | 47 |
vena cava | 47 |
induce emesis | 47 |
infectious respiratory | 47 |
alp activity | 47 |
female dogs | 47 |
dogs presented | 47 |
dog bites | 46 |
laboratory animal | 46 |
west highland | 46 |
respiratory rate | 46 |
feline immunodeficiency | 46 |
significantly associated | 46 |
blood gas | 46 |
cardiac output | 46 |
cell lymphomas | 45 |
teaching hospital | 45 |
see table | 45 |
underlying disease | 45 |
abdominal radiographs | 45 |
two groups | 45 |
older dogs | 45 |
dog populations | 45 |
north america | 45 |
bacterial culture | 45 |
copper accumulation | 45 |
intraocular pressure | 45 |
platelet count | 45 |
rabies control | 45 |
common cause | 44 |
experimental infection | 44 |
serum bile | 44 |
perform orogastric | 44 |
white blood | 44 |
four dogs | 44 |
may reveal | 44 |
human beings | 44 |
important role | 44 |
equi subsp | 44 |
cell count | 44 |
companion animal | 44 |
one case | 44 |
biopsy specimens | 43 |
diagnostic tests | 43 |
blast cells | 43 |
dogs showed | 43 |
case report | 43 |
also known | 43 |
diabetic cats | 43 |
alimentary lymphoma | 43 |
infected cats | 43 |
condition score | 43 |
amino acids | 43 |
adverse events | 43 |
animal species | 43 |
lateral recumbency | 43 |
pilot study | 43 |
serum biochemistry | 43 |
cell lines | 42 |
nonregenerative anemia | 42 |
radiation therapy | 42 |
may appear | 42 |
human rabies | 42 |
dog breeds | 42 |
seven dogs | 42 |
nodular hyperplasia | 42 |
mediated hemolytic | 42 |
administer intravenous | 42 |
reference range | 42 |
signs include | 42 |
canine leishmaniasis | 42 |
nyctereutes procyonoides | 42 |
crystalloid fluids | 42 |
systemic disease | 41 |
large number | 41 |
metabolic acidosis | 41 |
blood smear | 41 |
logistic regression | 41 |
lymphoid tissues | 41 |
clinical findings | 41 |
acute phase | 41 |
bile acid | 41 |
animal welfare | 41 |
regional lymph | 40 |
may lead | 40 |
respiratory coronavirus | 40 |
virus infection | 40 |
enzyme activities | 40 |
serum concentrations | 40 |
pulmonary hypertension | 40 |
supportive care | 40 |
twice daily | 40 |
infected animals | 40 |
lesions may | 40 |
room temperature | 40 |
bacterial infection | 40 |
hepatic lipidosis | 40 |
respiratory signs | 40 |
clinical features | 40 |
six dogs | 40 |
hematopoietic cells | 39 |
serum alp | 39 |
dogs diagnosed | 39 |
hepatic failure | 39 |
case series | 39 |
within days | 39 |
enzyme activity | 39 |
acute hepatitis | 39 |
less common | 39 |
vascular spaces | 39 |
sterile saline | 39 |
examination findings | 39 |
transfusion reaction | 39 |
nine dogs | 39 |
surgical excision | 38 |
obese dogs | 38 |
within minutes | 38 |
flow cytometry | 38 |
liver function | 38 |
positive results | 38 |
weighted images | 38 |
chronic liver | 38 |
saline solution | 38 |
kg hour | 38 |
marrow aspiration | 38 |
congenital portosystemic | 38 |
dog vaccination | 38 |
early stages | 37 |
carbon dioxide | 37 |
analyzed using | 37 |
significantly increased | 37 |
tumor cells | 37 |
vaccinated dogs | 37 |
kg minute | 37 |
lymphoid tissue | 37 |
type i | 37 |
two cats | 37 |
time points | 37 |
cell types | 37 |
airway obstruction | 37 |
previously described | 37 |
alkaline phosphatase | 37 |
inflammatory cells | 37 |
long axis | 37 |
pulp vascular | 37 |
severe cases | 37 |
study period | 37 |
serum alt | 37 |
endotracheal tube | 37 |
animals may | 37 |
liver failure | 37 |
serum creatinine | 37 |
dogs without | 37 |
also may | 37 |
prospective study | 37 |
current study | 36 |
statistical significance | 36 |
less frequently | 36 |
clinically healthy | 36 |
body fat | 36 |
high prevalence | 36 |
cardiac disease | 36 |
lymphatic vessels | 36 |
feline leukemia | 36 |
virus isolation | 36 |
poor prognosis | 36 |
five dogs | 35 |
acute hepatic | 35 |
hepatic abscesses | 35 |
type ii | 35 |
nasal cavity | 35 |
veterinary teaching | 35 |
acute respiratory | 35 |
cytologic examination | 35 |
caudal vena | 35 |
hepatic dysfunction | 35 |
adult cats | 35 |
dogs received | 35 |
previous studies | 35 |
chronic kidney | 35 |
ehrlichia canis | 35 |
pet dogs | 35 |
study showed | 34 |
dogs infected | 34 |
measured using | 34 |
research setting | 34 |
acute onset | 34 |
cell tumor | 34 |
creatinine ratio | 34 |
toxoplasma gondii | 34 |
multicentric lymphoma | 34 |
one report | 34 |
platelet function | 34 |
right lateral | 34 |
may indicate | 34 |
leukemia virus | 34 |
bacterial infections | 34 |
serum albumin | 34 |
cells may | 34 |
visceral leishmaniasis | 34 |
adenovirus type | 34 |
given orally | 33 |
hyperthyroid cats | 33 |
made based | 33 |
ae sd | 33 |
wild animals | 33 |
domestic cats | 33 |
leishmania infantum | 33 |
stem cells | 33 |
bartonella spp | 33 |
disease severity | 33 |
royal canin | 33 |
anterior uveitis | 33 |
intravenous catheter | 33 |
feline coronavirus | 33 |
diagnostic imaging | 33 |
pulmonary artery | 33 |
faecal samples | 33 |
mycoplasma spp | 33 |
viral shedding | 33 |
disease may | 33 |
veterinary patients | 33 |
gauge needle | 33 |
intravenous crystalloid | 33 |
results indicate | 33 |
several studies | 32 |
wild carnivores | 32 |
findings include | 32 |
disease processes | 32 |
adverse reactions | 32 |
small dogs | 32 |
urinary catheter | 32 |
blood smears | 32 |
white matter | 32 |
red cell | 32 |
sample collection | 32 |
even though | 32 |
mesenteric lymph | 32 |
ciliary body | 32 |
fatty acids | 32 |
gold standard | 32 |
contigs singletons | 32 |
classification system | 32 |
risk factor | 31 |
gi tract | 31 |
different breeds | 31 |
total protein | 31 |
hepatic fibrosis | 31 |
streptococcus equi | 31 |
significantly decreased | 31 |
mean ae | 31 |
feline lymphoma | 31 |
bronchiolitis obliterans | 31 |
positive dogs | 31 |
organ dysfunction | 31 |
common clinical | 31 |
canine hepatitis | 31 |
regression analysis | 31 |
escherichia coli | 31 |
mammary tumors | 31 |
dog nyctereutes | 31 |
lymphatic system | 31 |
lens luxation | 31 |
experimentally infected | 31 |
dogs receiving | 31 |
oral administration | 31 |
wound healing | 30 |
one health | 30 |
left shift | 30 |
intravenous fluid | 30 |
tract disease | 30 |
medical therapy | 30 |
case reports | 30 |
eight dogs | 30 |
hepatocellular carcinoma | 30 |
systemic chemotherapy | 30 |
infection may | 30 |
samples collected | 30 |
clinical trial | 30 |
lymphocytic leukemia | 30 |
cause severe | 30 |
animal shelter | 30 |
may help | 30 |
treatment consists | 30 |
lung lobe | 30 |
less commonly | 30 |
clotting factors | 30 |
biochemistry profile | 30 |
jugular vein | 30 |
dry weight | 30 |
iron deficiency | 30 |
pulmonary fibrosis | 30 |
urine samples | 30 |
body mass | 30 |
recent study | 30 |
smooth muscle | 30 |
considered significant | 30 |
urine output | 30 |
mass effect | 29 |
monoclonal gammopathy | 29 |
airway disease | 29 |
affected cats | 29 |
small number | 29 |
may play | 29 |
may become | 29 |
class ii | 29 |
essential thrombocythemia | 29 |
mechanical ventilation | 29 |
local anesthetic | 29 |
acid concentrations | 29 |
one third | 29 |
cell counts | 29 |
portal blood | 29 |
serum chemistry | 29 |
cell volume | 29 |
laboratory findings | 29 |
chronic enteropathies | 29 |
animal medicine | 29 |
histopathologic examination | 29 |
world health | 29 |
medical management | 29 |
acute liver | 29 |
biopsy samples | 29 |
healthy adult | 29 |
pg ml | 29 |
platelet counts | 29 |
years old | 29 |
consecutive days | 29 |
golden retrievers | 29 |
upper airway | 29 |
helicobacter spp | 29 |
anaplasma phagocytophilum | 28 |
flow cytometric | 28 |
progenitor cells | 28 |
liquid chromatography | 28 |
clinical examination | 28 |
liver enzymes | 28 |
connective tissue | 28 |
health organization | 28 |
capillary refill | 28 |
serum biochemical | 28 |
clinically ill | 28 |
serum tt | 28 |
antibody titers | 28 |
white pulp | 28 |
hepatic parenchyma | 28 |
abdominal cavity | 28 |
combination chemotherapy | 28 |
renal tubular | 28 |
white terriers | 28 |
catheter placement | 28 |
mast cells | 28 |
copper concentrations | 28 |
refill time | 28 |
stem cell | 28 |
mediated thrombocytopenia | 28 |
urea nitrogen | 28 |
infectious canine | 28 |
stray dogs | 28 |
reactive protein | 28 |
dog rabies | 28 |
common finding | 28 |
acute pancreatitis | 28 |
intestinal tract | 28 |
pulse oximetry | 28 |
total number | 28 |
blood loss | 28 |
small intestinal | 28 |
ml syringe | 28 |
platelet aggregation | 28 |
portal venous | 27 |
sirs criteria | 27 |
surgical treatment | 27 |
confidence interval | 27 |
exact test | 27 |
normal range | 27 |
contrast medium | 27 |
internal medicine | 27 |
insulin resistance | 27 |
common causes | 27 |
hepatic function | 27 |
test results | 27 |
rectal temperature | 27 |
biomedical research | 27 |
gastrointestinal signs | 27 |
autosomal recessive | 27 |
based protocols | 27 |
chronic disease | 27 |
veterinary literature | 27 |
electron microscopy | 27 |
another study | 27 |
systolic blood | 27 |
previously reported | 27 |
electrolyte abnormalities | 27 |
systemic inflammatory | 27 |
severe clinical | 27 |
parvoviral enteritis | 27 |
treated dogs | 27 |
emergency care | 27 |
make sure | 27 |
dog dreams | 27 |
specific gravity | 27 |
fatty acid | 26 |
linear regression | 26 |
clinically significant | 26 |
pcr assay | 26 |
extramedullary plasmacytoma | 26 |
intravascular hemolysis | 26 |
cytosine arabinoside | 26 |
may contribute | 26 |
induced liver | 26 |
repeated measures | 26 |
contrast enhancement | 26 |
clinical improvement | 26 |
population dynamics | 26 |
three cats | 26 |
positive correlation | 26 |
inflammatory diseases | 26 |
may provide | 26 |
often used | 26 |
cardiac dysrhythmias | 26 |
needle biopsy | 26 |
three times | 26 |
prothrombin time | 26 |
wide variety | 26 |
marginal sinus | 26 |
pale mucous | 26 |
serum protein | 26 |
per cent | 26 |
small amounts | 26 |
scoring system | 26 |
animal shelters | 26 |
mixed breed | 26 |
pet owners | 26 |
exocrine pancreatic | 26 |
high levels | 26 |
venous blood | 26 |
cocker spaniels | 26 |
initial treatment | 26 |
kennel cough | 26 |
study aimed | 26 |
critically ill | 26 |
complete response | 26 |
pcr positive | 26 |
immune function | 26 |
head trauma | 26 |
time point | 26 |
histiocytic sarcoma | 25 |
significant increase | 25 |
central venous | 25 |
transfusion reactions | 25 |
oral cavity | 25 |
four cats | 25 |
less likely | 25 |
diagnostic tool | 25 |
information regarding | 25 |
rate infusion | 25 |
clinically normal | 25 |
susceptibility testing | 25 |
cytologic evaluation | 25 |
commonly affected | 25 |
cerebral edema | 25 |
optic nerve | 25 |
animal practice | 25 |
per year | 25 |
higher risk | 25 |
vascular access | 25 |
acth stimulation | 25 |
immune responses | 25 |
shepherd dogs | 25 |
life cycle | 25 |
bronchoalveolar lavage | 25 |
organ systems | 25 |
high risk | 25 |
iv cri | 25 |
mitral regurgitation | 25 |
kg sq | 25 |
clinical course | 25 |
pulmonary arterial | 25 |
health status | 25 |
prognostic value | 25 |
hyperviscosity syndrome | 25 |
response rates | 25 |
causative agent | 25 |
canine population | 25 |
treatment groups | 25 |
blood supply | 24 |
neutrophilic pleocytosis | 24 |
inflammatory disease | 24 |
standard deviation | 24 |
clinical illness | 24 |
small cell | 24 |
pet ownership | 24 |
several days | 24 |
domestic shorthair | 24 |
serum total | 24 |
parvovirus infection | 24 |
nucleic acid | 24 |
final diagnosis | 24 |
poorly differentiated | 24 |
tissue samples | 24 |
therapy may | 24 |
king charles | 24 |
canine astrovirus | 24 |
cardiac injury | 24 |
factor viii | 24 |
negative control | 24 |
clinical manifestations | 24 |
surface area | 24 |
hematopoietic tumors | 24 |
canis infection | 24 |
blood ammonia | 24 |
hepatic lesions | 24 |
study population | 24 |
significant correlation | 24 |
myeloid leukemia | 24 |
severe anemia | 24 |
blood donors | 24 |
maintain hydration | 24 |
national park | 24 |
left atrium | 24 |
feeding tube | 24 |
rabies deaths | 24 |
positive samples | 24 |
acute renal | 24 |
mortality rate | 24 |
blood type | 24 |
lymphoid follicles | 24 |
one hundred | 24 |
red fox | 24 |
common bile | 24 |
myelomonocytic leukemia | 24 |
acute diarrhoea | 24 |
widely used | 24 |
among dogs | 24 |
every weeks | 24 |
wall thickness | 24 |
elevated protein | 24 |
dogs using | 23 |
labrador retriever | 23 |
surgical intervention | 23 |
commonly associated | 23 |
blood products | 23 |
soft palate | 23 |
lung disease | 23 |
plasma concentrations | 23 |
serum potassium | 23 |
clinical data | 23 |
golden retriever | 23 |
dogs naturally | 23 |
growth factors | 23 |
time rt | 23 |
extrahepatic biliary | 23 |
cavalier king | 23 |
wide range | 23 |
reference intervals | 23 |
muscle tremors | 23 |
ocular discharge | 23 |
dogs affected | 23 |
ethylene glycol | 23 |
treatment group | 23 |
retinal detachment | 23 |
predisposing factors | 23 |
infectious tracheobronchitis | 23 |
clinically relevant | 23 |
right ventricular | 23 |
ocular disease | 23 |
hemolytic transfusion | 23 |
zoonotic diseases | 23 |
germinal centers | 23 |
hypovolemic shock | 23 |
factors associated | 23 |
lavage fluid | 23 |
catheter insertion | 23 |
included dogs | 23 |
large breed | 23 |
liver may | 23 |
cats may | 23 |
normal cats | 23 |
pcr assays | 23 |
systematic review | 23 |
several months | 23 |
lymphoid lymphatic | 23 |
aspiration pneumonia | 23 |
primary liver | 23 |
long term | 23 |
blood sample | 23 |
upper limit | 23 |
tissue damage | 23 |
aseptically scrub | 23 |
acute hemolytic | 23 |
polycythemia vera | 23 |
acinar cells | 23 |
additional information | 22 |
gi disease | 22 |
right atrium | 22 |
thyroid hormone | 22 |
also observed | 22 |
may present | 22 |
sick dogs | 22 |
ultrasonographic findings | 22 |
canine cutaneous | 22 |
cipf whwts | 22 |
occurs within | 22 |
cell carcinoma | 22 |
renal perfusion | 22 |
ocular lesions | 22 |
clinical sign | 22 |
without clinical | 22 |
large cell | 22 |
protein concentrations | 22 |
modified live | 22 |
atrial fibrillation | 22 |
vast majority | 22 |
dp dt | 22 |
human albumin | 22 |
united kingdom | 22 |
young animals | 22 |
ventricular dysrhythmias | 22 |
oxygen delivery | 22 |
blood collection | 22 |
small amount | 22 |
intestinal lymphoma | 22 |
rabies vaccination | 22 |
rabies virus | 22 |
sarcoptic mange | 22 |
animal hospital | 22 |
cell mass | 22 |
spectrum antibiotics | 22 |
determined using | 22 |
surgical removal | 22 |
control cats | 22 |
zone lymphoma | 22 |
acral lick | 22 |
pancreatic parenchyma | 22 |
two different | 22 |
hepatic diseases | 22 |
ammonia concentration | 22 |
affected area | 22 |
respiratory infections | 22 |
described previously | 22 |
large amounts | 22 |
renal lymphoma | 22 |
will help | 22 |
sternal recumbency | 22 |
uric acid | 22 |
evaluated using | 22 |
clot formation | 22 |
age years | 22 |
first time | 22 |
infectious causes | 22 |
constant rate | 22 |
corticosteroid therapy | 21 |
parainfluenza virus | 21 |
copper content | 21 |
hypertrophic cardiomyopathy | 21 |
shih tzu | 21 |
urethral obstruction | 21 |
cns excitation | 21 |
glucose concentrations | 21 |
biopsy specimen | 21 |
serum crp | 21 |
western blot | 21 |
may increase | 21 |
clinical practice | 21 |
severe disease | 21 |
older cats | 21 |
per day | 21 |
may contain | 21 |
ill dogs | 21 |
ear canal | 21 |
cobalamin concentrations | 21 |
clinical cases | 21 |
intestinal inflammation | 21 |
rescue dogs | 21 |
become infected | 21 |
diagnostic procedures | 21 |
also cause | 21 |
odds ratio | 21 |
least two | 21 |
protein electrophoresis | 21 |
approximately one | 21 |
crp concentrations | 21 |
suppurative meningoencephalitis | 21 |
kg given | 21 |
acute leukemia | 21 |
inflammatory cytokines | 21 |
blood transfusion | 21 |
cell immunophenotype | 21 |
veterinary internal | 21 |
diagnostic test | 21 |
tract infection | 21 |
heartworm disease | 21 |
reference values | 21 |
success rate | 21 |
monoclonal gammopathies | 21 |
preliminary results | 21 |
increased liver | 21 |
intercostal space | 21 |
well tolerated | 21 |
bence jones | 21 |
inflammatory mediators | 21 |
include vomiting | 21 |
veterinary hospital | 21 |
nonsteroidal antiinflammatory | 21 |
year old | 21 |
compared using | 21 |
histologically confirmed | 21 |
biliary obstruction | 21 |
hepatic insufficiency | 21 |
neoplastic lymphocytes | 21 |
calculated using | 21 |
short axis | 21 |
creatinine concentration | 21 |
viral infection | 21 |
megakaryoblastic leukemia | 21 |
copper toxicosis | 21 |
clinical diagnosis | 20 |
von willebrand | 20 |
diffuse large | 20 |
spotted fever | 20 |
often present | 20 |
real time | 20 |
control seizures | 20 |
usually present | 20 |
hepatic enzyme | 20 |
prognostic factors | 20 |
increased numbers | 20 |
malignant lymphoma | 20 |
statistical association | 20 |
subcutaneous tissues | 20 |
reference ranges | 20 |
warm water | 20 |
source dogs | 20 |
antimicrobial resistance | 20 |
clinical outcome | 20 |
complete genome | 20 |
crystalloid fluid | 20 |
total body | 20 |
population size | 20 |
state university | 20 |
may allow | 20 |
usually occurs | 20 |
congenital hepatic | 20 |
tumors may | 20 |
control horses | 20 |
future studies | 20 |
tract infections | 20 |
chronic hepatic | 20 |
morphologic features | 20 |
recent years | 20 |
cut surface | 20 |
commonly observed | 20 |
mediastinal lymphoma | 20 |
roaming dogs | 20 |
serum concentration | 20 |
toxicity include | 20 |
meq kg | 20 |
south africa | 20 |
corneal ulcers | 20 |
young children | 20 |
cell line | 20 |
blood donor | 20 |
rarely reported | 20 |
single agent | 20 |
clinical symptoms | 20 |
exercise intolerance | 20 |
clinical relevance | 20 |
diaphragmatic hernia | 20 |
systolic function | 20 |
neospora caninum | 20 |
veterinary practice | 20 |
often associated | 20 |
imaging findings | 20 |
plasma samples | 20 |
rpad index | 20 |
chronic inflammatory | 20 |
skeletal muscle | 20 |
packed cell | 20 |
may induce | 20 |
mononuclear cells | 20 |
occur secondary | 20 |
control study | 20 |
presumptive diagnosis | 20 |
also reported | 20 |
healthy horses | 20 |
malignant cells | 20 |
currently available | 20 |
round cell | 20 |
may reflect | 20 |
urine specific | 20 |
severe hepatic | 20 |
liver tissue | 20 |
reported cases | 20 |
canine patients | 20 |
fungal infections | 20 |
fibrous tissue | 20 |
image quality | 20 |
complete remission | 20 |
dogs used | 20 |
interstitial pneumonia | 20 |
septic shock | 20 |
plasma concentration | 19 |
laryngeal paralysis | 19 |
pleural fluid | 19 |
age groups | 19 |
staging system | 19 |
coagulation factors | 19 |
dogs underwent | 19 |
sodium bicarbonate | 19 |
genomic dna | 19 |
severely affected | 19 |
coronavirus infection | 19 |
gastroprotectant drugs | 19 |
endemic areas | 19 |
kupffer cells | 19 |
response syndrome | 19 |
also result | 19 |
right ventricle | 19 |
also found | 19 |
much less | 19 |
macrophage system | 19 |
acute myeloid | 19 |
hepatic involvement | 19 |
cats presented | 19 |
veterinary clinics | 19 |
normal horses | 19 |
kg orally | 19 |
innate immune | 19 |
positive cells | 19 |
time period | 19 |
may show | 19 |
domestic short | 19 |
fiv infection | 19 |
cause clinical | 19 |
femoral artery | 19 |
io catheter | 19 |
ranging dogs | 19 |
myelogenous leukemia | 19 |
high serum | 19 |
six healthy | 19 |
oncotic pressure | 19 |
shepherd dog | 19 |
canine blood | 19 |
rabies elimination | 19 |
severe respiratory | 19 |
focal lesions | 19 |
ultrasound examination | 19 |
dogs died | 19 |
liver biopsies | 19 |
primary disease | 19 |
diagnoses include | 19 |
myxomatous mitral | 19 |
laboratory animals | 19 |
cns depression | 19 |
negative results | 19 |
extramedullary plasmacytomas | 19 |
felv infection | 19 |
plasma creatinine | 19 |
partial thromboplastin | 19 |
monoclonal antibodies | 19 |
situ hybridization | 19 |
wild dog | 19 |
lymphoid cells | 19 |
csf analysis | 19 |
significantly reduced | 19 |
occur within | 19 |
intervertebral disk | 19 |
white terrier | 19 |
significant changes | 19 |
nucleated cells | 19 |
three groups | 19 |
term survival | 19 |
overall survival | 19 |
data suggest | 19 |
scalpel blade | 19 |
false positive | 19 |
vascular endothelial | 19 |
serum levels | 19 |
blood transfusions | 19 |
owned cats | 19 |
blood sampling | 19 |
basophilic leukemia | 19 |
myeloid neoplasms | 18 |
third eyelid | 18 |
cns lymphoma | 18 |
mean body | 18 |
skin surface | 18 |
approximately days | 18 |
deficiency anemia | 18 |
significantly greater | 18 |
pulmonary disease | 18 |
glucose levels | 18 |
cell surface | 18 |
dogs presenting | 18 |
unknown origin | 18 |
bcs model | 18 |
antiinflammatory drugs | 18 |
lymphocyte count | 18 |
dogs also | 18 |
lower respiratory | 18 |
renal damage | 18 |
biochemical profile | 18 |
feline blood | 18 |
herpesvirus infection | 18 |
placebo group | 18 |
specific treatment | 18 |
duct obstruction | 18 |
stage iii | 18 |
activity may | 18 |
hours post | 18 |
lymphoma may | 18 |
lower urinary | 18 |
investigate whether | 18 |
neurological examination | 18 |
see also | 18 |
lick granuloma | 18 |
several times | 18 |
times daily | 18 |
pv pa | 18 |
study group | 18 |
within normal | 18 |
chemotherapeutic agents | 18 |
toxic potential | 18 |
grade lymphomas | 18 |
southeast asia | 18 |
including dogs | 18 |
leukemic cells | 18 |
interdigital cysts | 18 |
every days | 18 |
heart murmur | 18 |
tracheal collapse | 18 |
internal organs | 18 |
may predispose | 18 |
shelter dogs | 18 |
histopathological changes | 18 |
experimentally induced | 18 |
portosystemic shunt | 18 |
canine visceral | 18 |
interstitial lung | 18 |
endocrine cells | 18 |
cocker spaniel | 18 |
vaccine strains | 18 |
core biopsy | 18 |
higher prevalence | 18 |
aggressive therapy | 18 |
frequently reported | 18 |
respiratory syndrome | 18 |
treatment may | 18 |
abdominal effusion | 18 |
small breed | 18 |
mann whitney | 18 |
accurate diagnosis | 18 |
clinical significance | 18 |
endothelial cell | 18 |
disease caused | 18 |
correlation coefficient | 18 |
response rate | 18 |
chronic inflammation | 18 |
burn injury | 18 |
survival durations | 18 |
subcutaneous tissue | 18 |
rare cases | 18 |
poor outcome | 18 |
prognostic information | 18 |
zoonotic disease | 18 |
classification systems | 18 |
negative pressure | 18 |
cluster seizures | 18 |
coagulation factor | 18 |
intervertebral disc | 18 |
bred dogs | 18 |
positively correlated | 18 |
canine chronic | 18 |
analgesic drugs | 18 |
lyme disease | 18 |
right parasternal | 18 |
hemoglobin concentration | 18 |
bleeding time | 18 |
small numbers | 17 |
increased alt | 17 |
vertebral canal | 17 |
laboratory tests | 17 |
underlying causes | 17 |
dogs compared | 17 |
pasteurella multocida | 17 |
veterinary medical | 17 |
reverse transcription | 17 |
radiographic signs | 17 |
needle aspirates | 17 |
diagnostic testing | 17 |
intact male | 17 |
catheter hub | 17 |
hip dysplasia | 17 |
granulation tissue | 17 |
elisa kit | 17 |
ventricular tachycardia | 17 |
relatively high | 17 |
lung injury | 17 |
toxic dose | 17 |
weight gain | 17 |
subarachnoid space | 17 |
biochemical abnormalities | 17 |
takes place | 17 |
secondary glaucoma | 17 |
acute myelomonocytic | 17 |
intrahepatic cholestasis | 17 |
southern finland | 17 |
high sensitivity | 17 |
cutaneous leishmaniasis | 17 |
iridocorneal angle | 17 |
adipose tissue | 17 |
mediastinal form | 17 |
systemic infection | 17 |
large numbers | 17 |
csf samples | 17 |
lung lobes | 17 |
molecular weight | 17 |
times higher | 17 |
anemia may | 17 |
cells also | 17 |
healthy controls | 17 |
cell population | 17 |
stimulation test | 17 |
mrna expression | 17 |
cell cycle | 17 |
central role | 17 |
surgical resection | 17 |
findings included | 17 |
detection dogs | 17 |
life span | 17 |
two cases | 17 |
normal serum | 17 |
may represent | 17 |
lymphoid organs | 17 |
bartonella henselae | 17 |
secondary lymphoid | 17 |
fine needle | 17 |
sudden onset | 17 |
several weeks | 17 |
group dogs | 17 |
rank test | 17 |
human health | 17 |
young cats | 17 |
canine parvoviral | 17 |
reactive hepatitis | 17 |
severe acute | 17 |
diagnostic accuracy | 17 |
healthy control | 17 |
elizabethan collar | 17 |
south america | 17 |
filtration rate | 17 |
specific antibodies | 17 |
certain breeds | 17 |
fluid analysis | 17 |
tested positive | 17 |
ibd dogs | 17 |
study evaluated | 17 |
surgical correction | 17 |
three days | 17 |
several factors | 17 |
mammary gland | 17 |
european countries | 17 |
first hours | 17 |
concurrent disease | 17 |
study suggest | 17 |
differ significantly | 17 |
past years | 17 |
kg body | 17 |
findings may | 17 |
bleeding diathesis | 17 |
effective treatment | 17 |
affected horses | 17 |
serum liver | 17 |
thoracic radiography | 17 |
leishmania spp | 17 |
days post | 17 |
urinary incontinence | 17 |
breed predisposition | 17 |
largely supportive | 17 |
soft tissues | 17 |
feline herpesvirus | 17 |
tract obstruction | 17 |
first report | 17 |
secondary bacterial | 17 |
low numbers | 17 |
small lymphocytes | 17 |
blood volume | 17 |
study included | 17 |
clostridium perfringens | 17 |
antigenic stimulation | 17 |
assessed using | 17 |
feline panleukopenia | 17 |
fresh whole | 17 |
shar pei | 17 |
canine parainfluenza | 17 |
anatomic location | 17 |
blood typing | 16 |
dog showed | 16 |
retinal hemorrhage | 16 |
intrahepatic bile | 16 |
lung tissue | 16 |
five cats | 16 |
dirofilaria immitis | 16 |
exploratory laparotomy | 16 |
liver lobe | 16 |
dorsal recumbency | 16 |
research studies | 16 |
cobalamin deficiency | 16 |
clinical staging | 16 |
pancreatic disease | 16 |
buffered formalin | 16 |
veterinary hospitals | 16 |
pericardial effusion | 16 |
peritoneal cavity | 16 |
free radical | 16 |
sequence analysis | 16 |
disease complex | 16 |
baseline cortisol | 16 |
still alive | 16 |
normal reference | 16 |
idiopathic pulmonary | 16 |
abdominal wall | 16 |
clinical study | 16 |
necrosis factor | 16 |
shar peis | 16 |
hepatic neoplasia | 16 |
pulmonic stenosis | 16 |
shunt attenuation | 16 |
ct scan | 16 |
medical treatment | 16 |
natural infection | 16 |
distress syndrome | 16 |
fluid volume | 16 |
primary hepatic | 16 |
panleukopenia virus | 16 |
injury may | 16 |
term management | 16 |
retrospective analysis | 16 |
positive cats | 16 |
sinus rhythm | 16 |
term prognosis | 16 |
involvement may | 16 |
vaccination history | 16 |
three cases | 16 |
influenza virus | 16 |
lymphoid hyperplasia | 16 |
canis familiaris | 16 |
tape measure | 16 |
tricuspid valve | 16 |
gas analysis | 16 |
disease transmission | 16 |
neurological deficits | 16 |
survival rate | 16 |
erythroid hyperplasia | 16 |
marrow infiltration | 16 |
doppler imaging | 16 |
irish wolfhounds | 16 |
kg im | 16 |
may remain | 16 |
diseases associated | 16 |
abdominal palpation | 16 |
nutritional support | 16 |
cell proliferation | 16 |
direct contact | 16 |
hepatic tissue | 16 |
systemic therapy | 16 |
echinococcus granulosus | 16 |
cell tumours | 16 |
statistical analyses | 16 |
significant effect | 16 |
fluorescent antibody | 16 |
study found | 16 |
necrotizing vasculitis | 16 |
qrs complex | 16 |
red rubber | 16 |
nucleated cell | 16 |
york city | 16 |
oxygen supplementation | 16 |
previous study | 16 |
pu pd | 16 |
grade iii | 16 |
cdv infection | 16 |
canine lymphomas | 16 |
cell membrane | 16 |
disease control | 16 |
glomerular filtration | 16 |
sample size | 16 |
fluid diuresis | 16 |
computed tomographic | 16 |
animal patients | 16 |
crp concentration | 16 |
study suggests | 16 |
ocular chv | 16 |
diagnostic evaluation | 16 |
slowly progressive | 16 |
within weeks | 16 |
clinical score | 16 |
brachial plexus | 16 |
skin scrapings | 16 |
abdominal organs | 16 |
dogs develop | 16 |
thromboplastin time | 16 |
mass spectrometry | 16 |
analysis showed | 16 |
pcr testing | 16 |
chi square | 16 |
chemotherapy protocol | 16 |
signs related | 16 |
fold increase | 16 |
hepatic biopsy | 16 |
cell type | 16 |
cardiovascular disease | 16 |
feline liver | 16 |
mature dogs | 16 |
may involve | 16 |
made using | 16 |
borne infections | 16 |
inclusion bodies | 16 |
age group | 16 |
central blindness | 16 |
multiple sites | 16 |
antibody levels | 16 |
echocardiographic parameters | 15 |
intrahepatic cpss | 15 |
predictive value | 15 |
immune status | 15 |
injection site | 15 |
german shepherds | 15 |
respiratory system | 15 |
marrow involvement | 15 |
male dog | 15 |
large granular | 15 |
lower airway | 15 |
little information | 15 |
initial diagnosis | 15 |
sodium chloride | 15 |
ventricular hypertrophy | 15 |
erythroid cells | 15 |
dead space | 15 |
carbonic anhydrase | 15 |
allergic reactions | 15 |
may suggest | 15 |
fluid samples | 15 |
multiple organ | 15 |
hind limb | 15 |
stroke volume | 15 |
parvovirus type | 15 |
may persist | 15 |
recent studies | 15 |
environmental factors | 15 |
study demonstrated | 15 |
organ failure | 15 |
total thyroxine | 15 |
cats received | 15 |
dogs include | 15 |
cobalamin concentration | 15 |
one month | 15 |
commonly seen | 15 |
asymptomatic dogs | 15 |
strain rate | 15 |
enteric viruses | 15 |
pathological findings | 15 |
chemistry profile | 15 |
chronic myelogenous | 15 |
six cats | 15 |
quantitative pcr | 15 |
monocytic leukemia | 15 |
yorkshire terrier | 15 |
laboratory abnormalities | 15 |
genetic factors | 15 |
iliac crest | 15 |
wedge biopsy | 15 |
administer supplemental | 15 |
mucous membrane | 15 |
body surface | 15 |
anion gap | 15 |
chronic respiratory | 15 |
abdominal ultrasonography | 15 |
observer agreement | 15 |
litter size | 15 |
normal values | 15 |
without evidence | 15 |
associated liver | 15 |
left lateral | 15 |
interstitial fibrosis | 15 |
control measures | 15 |
node involvement | 15 |
felv fiv | 15 |
mycosis fungoides | 15 |
canine ibd | 15 |
tissue sections | 15 |
serum ccl | 15 |
fatal disease | 15 |
serum sodium | 15 |
corpus callosum | 15 |
systemic circulation | 15 |
assess whether | 15 |
chronic lymphocytic | 15 |
increased significantly | 15 |
left ventricle | 15 |
fluid accumulation | 15 |
agglutination test | 15 |
pancreatic insufficiency | 15 |
iris stage | 15 |
systemic illness | 15 |
overall prevalence | 15 |
newly diagnosed | 15 |
evidence suggests | 15 |
first study | 15 |
campylobacter jejuni | 15 |
miniature schnauzers | 15 |
high grade | 15 |
type diabetes | 15 |
cause acute | 15 |
evaluate whether | 15 |
may serve | 15 |
oxidative damage | 15 |
extrahepatic portosystemic | 15 |
liver regeneration | 15 |
vaccination campaigns | 15 |
respiratory pattern | 15 |
protected areas | 15 |
higher incidence | 15 |
uniform splenomegaly | 15 |
extramedullary hematopoiesis | 15 |
intestinal obstruction | 15 |
several hours | 15 |
monocytic ehrlichiosis | 15 |
variable region | 15 |
inflammation may | 15 |
corticosteroid administration | 15 |
intravenous administration | 15 |
edta blood | 15 |
abnormalities may | 15 |
systemic hypertension | 15 |
increased production | 15 |
campylobacter spp | 15 |
idexx laboratories | 15 |
urine ph | 15 |
medial saphenous | 15 |
two weeks | 15 |
square test | 15 |
occurs primarily | 15 |
neurological disease | 15 |
culture results | 15 |
animal model | 15 |
vaccination status | 15 |
tumor necrosis | 15 |
mass dog | 15 |
primary cause | 15 |
unvaccinated dogs | 15 |
clinical trials | 15 |
weeks post | 15 |
molecular diagnostic | 15 |
pressure measurement | 15 |
canine leptospirosis | 15 |
dilated cardiomyopathy | 15 |
canine ehrlichiosis | 15 |
mammary tumours | 15 |
rocky mountain | 15 |
diagnostic value | 15 |
canine model | 15 |
zoonotic pathogens | 15 |
cranial fossa | 15 |
high resolution | 15 |
current veterinary | 15 |
adverse event | 15 |
also seen | 15 |
may reduce | 15 |
wound management | 15 |
screening test | 15 |
showed mild | 15 |
vaginal discharge | 15 |
rescue protocols | 15 |
dream recall | 15 |
cortisol concentrations | 14 |
hepatitis virus | 14 |
elevated serum | 14 |
cytometric analysis | 14 |
lung sounds | 14 |
will result | 14 |
echinococcus multilocularis | 14 |
renal insufficiency | 14 |
light chains | 14 |
wbc count | 14 |
also occurs | 14 |
nitric oxide | 14 |
cardiac diseases | 14 |
point scale | 14 |
cardiogenic shock | 14 |
results obtained | 14 |
clinical evidence | 14 |
liquid nitrogen | 14 |
vertebral heart | 14 |
using high | 14 |
burn wounds | 14 |
mixed cell | 14 |
maine coon | 14 |
free wall | 14 |
high concentrations | 14 |
study using | 14 |
frequently detected | 14 |
arterial pressure | 14 |
enlarged lymph | 14 |
myeloid cells | 14 |
significant decrease | 14 |
various breeds | 14 |
reserve capacity | 14 |
hunting dogs | 14 |
lupus erythematosus | 14 |
degenerative mitral | 14 |
extension tubing | 14 |
adult animals | 14 |
arterial hypertension | 14 |
study demonstrates | 14 |
remains unclear | 14 |
previously validated | 14 |
feline hyperthyroidism | 14 |
orally every | 14 |
without significant | 14 |
cells within | 14 |
antibiotic treatment | 14 |
gallbladder wall | 14 |
chronic active | 14 |
splenic capsule | 14 |
lobular dissecting | 14 |
previous bp | 14 |
cell neoplasms | 14 |
dietary supplements | 14 |
thoracic inlet | 14 |
intrahepatic shunts | 14 |
shorthair cats | 14 |
good quality | 14 |
bite wounds | 14 |
histopathologic evaluation | 14 |
nasal lymphoma | 14 |
cats suspected | 14 |
animal clinical | 14 |
clinical parameters | 14 |
diagnostic utility | 14 |
rectal swabs | 14 |
rubber catheter | 14 |
dark red | 14 |
smear evaluation | 14 |
serum urea | 14 |
endemic area | 14 |
glucose monitoring | 14 |
complete physical | 14 |
dissecting hepatitis | 14 |
transitional cell | 14 |
extrahepatic bile | 14 |
antimicrobial susceptibility | 14 |
cell death | 14 |
pelvic limbs | 14 |
one week | 14 |
chronic pain | 14 |
foreign material | 14 |
west nile | 14 |
see later | 14 |
tt concentrations | 14 |
vein hypoplasia | 14 |
clinical setting | 14 |
given intravenously | 14 |
lgl lymphoma | 14 |
two months | 14 |
initial therapy | 14 |
food intake | 14 |
average age | 14 |
total bilirubin | 14 |
red foxes | 14 |
population density | 14 |
portal scintigraphy | 14 |
neonatal isoerythrolysis | 14 |
also present | 14 |
heavy chain | 14 |
close contact | 14 |
cell neoplasia | 14 |
kit vegf | 14 |
neutralizing antibodies | 14 |
unknown whether | 14 |
days later | 14 |
babesia spp | 14 |
cardiac murmur | 14 |
drug administration | 14 |
lymphocytic pleocytosis | 14 |
research dogs | 14 |
wilcoxon signed | 14 |
radiographs may | 14 |
affected individuals | 14 |
vulpes vulpes | 14 |
nonspecific signs | 14 |
generalized demodicosis | 14 |
viral pathogens | 14 |
complete resolution | 14 |
increased hepatic | 14 |
occurs secondary | 14 |
left cranial | 14 |
monoclonal antibody | 14 |
months old | 14 |
negative dogs | 14 |
animal models | 14 |
syndrome associated | 14 |
high doses | 14 |
malignant tumors | 14 |
vein thrombosis | 14 |
subcutaneous fat | 14 |
histologic evidence | 14 |
splenic vein | 14 |
laboratory setting | 14 |
see box | 14 |
toxic effects | 14 |
hours following | 14 |
unpublished data | 14 |
systemic inflammation | 14 |
ultrasonographic appearance | 14 |
canine leishmaniosis | 14 |
grade i | 14 |
ccl concentrations | 14 |
hepatocellular injury | 14 |
negative prognostic | 14 |
liver cell | 14 |
initial presentation | 14 |
diagnosis may | 14 |
veterinary therapy | 14 |
treatment protocols | 14 |
animal care | 14 |
previous research | 14 |
emergency treatment | 14 |
rickettsia rickettsii | 14 |
administer gastroprotectant | 14 |
post mortem | 14 |
active infection | 14 |
staphylococcus spp | 14 |
also called | 14 |
taking care | 14 |
study day | 14 |
supportive treatment | 14 |
cdv pcr | 14 |
extranodal forms | 14 |
significant association | 14 |
contrast agent | 14 |
borrelia burgdorferi | 14 |
viral rna | 14 |
ten dogs | 14 |
polycystic kidney | 14 |
cats receiving | 13 |
allergy dermatitis | 13 |
insulin secretion | 13 |
pathological changes | 13 |
enzyme elevations | 13 |
synovial fluid | 13 |
active ingredient | 13 |
hematopoietic cell | 13 |
like lymphoma | 13 |
proximal humerus | 13 |
coagulation parameters | 13 |
wound closure | 13 |
brain parenchyma | 13 |
respiratory pathogens | 13 |
protein content | 13 |
adult horses | 13 |
glass slide | 13 |
imaging features | 13 |
surgical procedures | 13 |
none required | 13 |
bone lesions | 13 |
iu kg | 13 |
one sample | 13 |
thoracostomy tube | 13 |
clinical conditions | 13 |
chv ocular | 13 |
cell cultures | 13 |
cells ml | 13 |
mortem examination | 13 |
overall median | 13 |
salmonella sp | 13 |
mitral valves | 13 |
treatment protocol | 13 |
losing enteropathy | 13 |
serum bilirubin | 13 |
serum ht | 13 |
neuter status | 13 |
trabecular meshwork | 13 |
affected tissues | 13 |
stomach tube | 13 |
way anova | 13 |
gastric ulcers | 13 |
healthy beagle | 13 |
endometrial hyperplasia | 13 |
biopsy site | 13 |
cdv isolates | 13 |
antiemetic drugs | 13 |
hepatic damage | 13 |
signs included | 13 |
almost always | 13 |
granulocytic leukemia | 13 |
seizure activity | 13 |
two major | 13 |
large bowel | 13 |
special stains | 13 |
three different | 13 |
often seen | 13 |
different types | 13 |
measures anova | 13 |
mitotic figures | 13 |
neurologic examination | 13 |
supportive therapy | 13 |
human deaths | 13 |
veterinary college | 13 |
metastatic disease | 13 |
large dogs | 13 |
streptococcus spp | 13 |
may aid | 13 |
arachidonic acid | 13 |
afferent lymphatic | 13 |
two main | 13 |
various forms | 13 |
chronic granulocytic | 13 |
doberman pinscher | 13 |
feline leukaemia | 13 |
disease status | 13 |
published data | 13 |
cardiac troponin | 13 |
spinal canal | 13 |
anim pract | 13 |
congenital heart | 13 |
clipped area | 13 |
digestive enzymes | 13 |
hepatic metabolism | 13 |
viral diseases | 13 |
hypothyroid dogs | 13 |
signal intensity | 13 |
associated lymphoid | 13 |
ultrasound guidance | 13 |
distal end | 13 |
leukaemia virus | 13 |
ggt activity | 13 |
experimental studies | 13 |
administer activated | 13 |
typically associated | 13 |
units kg | 13 |
procoagulant activity | 13 |
packed rbcs | 13 |
siamese cats | 13 |
intestinal wall | 13 |
term maintenance | 13 |
serum progesterone | 13 |
felv era | 13 |
previously published | 13 |
pure red | 13 |
one year | 13 |
findings suggest | 13 |
study provides | 13 |
crcov isolates | 13 |
biochemical analysis | 13 |
myelodysplastic syndromes | 13 |
cardiovascular status | 13 |
successful treatment | 13 |
viral loads | 13 |
pfizer animal | 13 |
samples obtained | 13 |
acute leukemias | 13 |
stage ii | 13 |
caudal cranial | 13 |
corneal edema | 13 |
cardiovascular system | 13 |
mass lesions | 13 |
mhc class | 13 |
medullary sinuses | 13 |
portal circulation | 13 |
canine adenoviruses | 13 |
humor production | 13 |
mountain spotted | 13 |
adrenal glands | 13 |
immunosuppressive therapy | 13 |
canine mammary | 13 |
pancreatic hypoplasia | 13 |
partial remission | 13 |
see chapters | 13 |
spinal pain | 13 |
anesthetic drugs | 13 |
groups using | 13 |
male cats | 13 |
heart size | 13 |
gi lymphoma | 13 |
mean arterial | 13 |
patient discomfort | 13 |
daily basis | 13 |
myelodysplastic syndrome | 13 |
brain barrier | 13 |
also play | 13 |
immunosorbent assay | 13 |
pleural space | 13 |
dreams including | 13 |
urine protein | 13 |
wall thickening | 13 |
daily administration | 13 |
respiratory status | 13 |
brachycephalic dogs | 13 |
abdominal fluid | 13 |
biopsy needle | 13 |
acvim class | 13 |
significantly correlated | 13 |
veterinary practices | 13 |
spec cpl | 13 |
disease associated | 13 |
serum half | 13 |
antibiotic ointment | 13 |
relative risk | 13 |
small anim | 13 |
serum hepatic | 13 |
previously presented | 13 |
one group | 13 |
using flow | 13 |
oxygen saturation | 13 |
shortening fraction | 13 |
known antidote | 13 |
spinal lymphoma | 13 |
receiver operating | 13 |
needle aspirate | 13 |
drug therapy | 13 |
hemorrhagic diarrhea | 13 |
better prognosis | 13 |
primary glaucoma | 13 |
phylogenetic analysis | 13 |
dogs living | 13 |
caloric intake | 13 |
foreign object | 13 |
cord compression | 13 |
normal canine | 13 |
biochemical findings | 13 |
coagulation abnormalities | 13 |
high frequency | 13 |
cell aplasia | 13 |
additional diagnostic | 13 |
time required | 13 |
die within | 13 |
low levels | 13 |
histologic features | 13 |
acute nonlymphocytic | 13 |
phase i | 13 |
significant statistical | 13 |
troponin i | 13 |
within hour | 13 |
cats include | 13 |
porcine circovirus | 13 |
veterinary species | 13 |
lateral ventricles | 13 |
contact layer | 13 |
giant cells | 13 |
like growth | 13 |
frequently observed | 13 |
viral dna | 13 |
remains unknown | 13 |
oral cobalamin | 13 |
per os | 13 |
results showed | 13 |
thermal burns | 13 |
systemic signs | 13 |
glucose concentration | 13 |
also possible | 13 |
alkylating agent | 13 |
host range | 13 |
articular cartilage | 13 |
granulomatous hepatitis | 13 |
cairn terriers | 13 |
serum piiinp | 13 |
infectious agent | 13 |
older animals | 13 |
concentration may | 13 |
atlantic forest | 13 |
individual dog | 13 |
relatively common | 13 |
omeprazole treatment | 13 |
matched control | 13 |
mri findings | 13 |
charles spaniel | 13 |
paraneoplastic syndrome | 13 |
combination protocols | 13 |
population management | 13 |
secondary infections | 13 |
geriatric cats | 13 |
responsive meningitis | 13 |
acute disease | 13 |
rv function | 13 |
imaging modality | 13 |
normal tissue | 13 |
active metabolite | 13 |
tissue perfusion | 13 |
fractional shortening | 13 |
intracranial pressure | 12 |
diagnostic sensitivity | 12 |
corneal ulceration | 12 |
longitudinal study | 12 |
mg po | 12 |
pulmonary parenchymal | 12 |
ast activity | 12 |
rich plasma | 12 |
surgical management | 12 |
decreased production | 12 |
artificial insemination | 12 |
veress needle | 12 |
detection limit | 12 |
herpes virus | 12 |
potential risk | 12 |
liver fibrosis | 12 |
transit times | 12 |
endotracheal intubation | 12 |
relative expression | 12 |
ventricular septal | 12 |
consistent finding | 12 |
acth cortisol | 12 |
renal dysfunction | 12 |
less invasive | 12 |
heparinized saline | 12 |
dermal exposure | 12 |
ejection fraction | 12 |
hepatic inflammation | 12 |
tap water | 12 |
antibody titer | 12 |
type iii | 12 |
birth canal | 12 |
abdominal mass | 12 |
chemotherapeutic drugs | 12 |
confidence intervals | 12 |
respiratory failure | 12 |
survey radiographs | 12 |
significant clinical | 12 |
animal may | 12 |
frequently used | 12 |
po bid | 12 |
flea allergy | 12 |
pi concentrations | 12 |
clinical response | 12 |
choroid plexus | 12 |
domestic cat | 12 |
commonly found | 12 |
lung lavage | 12 |
financial support | 12 |
dogs tested | 12 |
small bowel | 12 |
physical examinations | 12 |
important cause | 12 |
often occurs | 12 |
venous pressure | 12 |
environmental conditions | 12 |
clinical studies | 12 |
storage pool | 12 |
closely related | 12 |
remaining dogs | 12 |
mediastinal mass | 12 |
hour period | 12 |
lipid peroxidation | 12 |
kg hr | 12 |
seen within | 12 |
months following | 12 |
regenerative response | 12 |
dogs fed | 12 |
ownerless dogs | 12 |
fat percentage | 12 |
mixed model | 12 |
color doppler | 12 |
hepatic neoplasms | 12 |
liver tumors | 12 |
microvascular dysplasia | 12 |
animal reproduction | 12 |
relatively small | 12 |
classified according | 12 |
studies evaluating | 12 |
gastrointestinal lymphoma | 12 |
molecular techniques | 12 |
varying degrees | 12 |
active hepatitis | 12 |
tzu dogs | 12 |
gene mutations | 12 |
defense mechanisms | 12 |
privately owned | 12 |
pancreatic tissue | 12 |
fecal flotation | 12 |
water bath | 12 |
nested pcr | 12 |
lamina propria | 12 |
cd vegf | 12 |
transit time | 12 |
early stage | 12 |
antimicrobial therapy | 12 |
retrospectively reviewed | 12 |
rhipicephalus sanguineus | 12 |
systemic involvement | 12 |
highly variable | 12 |
nmoles min | 12 |
serum viscosity | 12 |
personal communication | 12 |
liver cancer | 12 |
atrial standstill | 12 |
parasitic infections | 12 |
extrahepatic cpss | 12 |
medullary cords | 12 |
may take | 12 |
poorly understood | 12 |
packed red | 12 |
nile virus | 12 |
hepatic parenchymal | 12 |
kg bid | 12 |
puppies may | 12 |
lens capsule | 12 |
severe inflammation | 12 |
diagnostic techniques | 12 |
cats treated | 12 |
without treatment | 12 |
whipworm infestation | 12 |
linked immunosorbent | 12 |
diabetic dogs | 12 |
gray matter | 12 |
patient may | 12 |
annular hypoplasia | 12 |
tissue doppler | 12 |
inflammatory process | 12 |
used successfully | 12 |
acute abdominal | 12 |
clinical syndrome | 12 |
rodenticide intoxication | 12 |
bacterial groups | 12 |
control groups | 12 |
cell morphology | 12 |
enteric coronavirus | 12 |
neurologic disease | 12 |
prostatic fluid | 12 |
systemic diseases | 12 |
minute iv | 12 |
coagulation tests | 12 |
systemic blood | 12 |
coagulation disorders | 12 |
human disease | 12 |
young adult | 12 |
ecchymotic hemorrhages | 12 |
dog acute | 12 |
retrospective evaluation | 12 |
cardiac size | 12 |
authors declare | 12 |
bacterial species | 12 |
calcium gluconate | 12 |
endoscopic biopsies | 12 |
limited number | 12 |
induced hepatic | 12 |
systemic spread | 12 |
mycobacterium avium | 12 |
alt levels | 12 |
urban areas | 12 |
mr images | 12 |
study investigated | 12 |
paraneoplastic syndromes | 12 |
intestinal disease | 12 |
animals will | 12 |
baseline values | 12 |
many cats | 12 |
often reveals | 12 |
catheter site | 12 |
host immune | 12 |
doppler ultrasound | 12 |
tick paralysis | 12 |
zymogen granules | 12 |
recall frequency | 12 |
six months | 12 |
needle catheter | 12 |
pupil size | 12 |
laboratory data | 12 |
group compared | 12 |
least weeks | 12 |
acetaminophen toxicity | 12 |
oxygen therapy | 12 |
curve analysis | 12 |
transmissible venereal | 12 |
jones proteinuria | 12 |
higher percentage | 12 |
mildly increased | 12 |
mmol mol | 12 |
hemolytic anemias | 12 |
antigen test | 12 |
persian cats | 12 |
apparently healthy | 12 |
analysed using | 12 |
feline population | 12 |
southern germany | 12 |
chronic bronchitis | 12 |
posterior chamber | 12 |
asymptomatic carriers | 12 |
young dog | 12 |
marked increase | 12 |
lymphoid atrophy | 12 |
autoimmune hepatitis | 12 |
normal csf | 12 |
pancreatic duct | 12 |
viral load | 12 |
dipylidium caninum | 12 |
mortality rates | 12 |
haemorrhagic diarrhoea | 12 |
acute haemorrhagic | 12 |
old male | 12 |
min mg | 12 |
animal veterinary | 12 |
literature review | 12 |
highly pathogenic | 12 |
portosystemic vascular | 12 |
cats presenting | 12 |
vacuolar hepatopathy | 12 |
test food | 12 |
increased iop | 12 |
cardiac function | 12 |
dogs undergoing | 12 |
plasma phosphate | 12 |
maintenance therapy | 12 |
discussed later | 12 |
liver involvement | 12 |
significant risk | 12 |
repeated doses | 12 |
thoracic cavity | 12 |
geographic distribution | 12 |
prospective studies | 12 |
increased respiratory | 12 |
intact females | 12 |
cortisol concentration | 11 |
systemic lupus | 11 |
regular insulin | 11 |
lung function | 11 |
cats without | 11 |
diseases including | 11 |
salmonella spp | 11 |
cooling measures | 11 |
useful information | 11 |
base status | 11 |
months later | 11 |
performance liquid | 11 |
different species | 11 |
factors include | 11 |
previous reports | 11 |
cervical spinal | 11 |
naturally acquired | 11 |
granulomatous inflammation | 11 |
available online | 11 |
bronchial lymph | 11 |
ocular inflammation | 11 |
suture material | 11 |
regenerative anemia | 11 |
diagnostic performance | 11 |
pressure sores | 11 |
english springer | 11 |
within reference | 11 |
healthy animals | 11 |
captive african | 11 |
transthoracic echocardiography | 11 |
blood urea | 11 |
disease agents | 11 |
consensus statement | 11 |
gross examination | 11 |
gastric emptying | 11 |
histologic examination | 11 |
pet animals | 11 |
cytoplasmic granules | 11 |
host species | 11 |
royal veterinary | 11 |
dogs following | 11 |
diagnostic workup | 11 |
cause disease | 11 |
bloody consistency | 11 |
thoracic duct | 11 |
shorter survival | 11 |
dogs developed | 11 |
based oxygen | 11 |
excessive bleeding | 11 |
vision loss | 11 |
induced illness | 11 |
aplastic anemia | 11 |
clinically affected | 11 |
alanine aminotransferase | 11 |
transport medium | 11 |
imaging modalities | 11 |
beta cells | 11 |
sled dogs | 11 |
toxic metabolites | 11 |
occurred within | 11 |
regression model | 11 |
outcome prediction | 11 |
smoke inhalation | 11 |
sterile gloves | 11 |
carrying capacity | 11 |
complications associated | 11 |
serum glucose | 11 |
topical anesthetic | 11 |
cardiogenic pulmonary | 11 |
respiratory function | 11 |
dogs included | 11 |
classification scheme | 11 |
peripheral lymph | 11 |
spleen may | 11 |
high mortality | 11 |
qt interval | 11 |
particular attention | 11 |
test result | 11 |
doppler echocardiography | 11 |
cell receptor | 11 |
probnp concentration | 11 |
current status | 11 |
viral disease | 11 |
impression smears | 11 |
veterinary clinical | 11 |
kg every | 11 |
neoplastic proliferation | 11 |
certain drugs | 11 |
willebrand disease | 11 |
dog may | 11 |
peritoneal effusion | 11 |
presenting signs | 11 |
inflammatory reaction | 11 |
methylene blue | 11 |
type dm | 11 |
metabolic syndrome | 11 |
identified using | 11 |
high level | 11 |
first remission | 11 |
peak velocity | 11 |
environmental contamination | 11 |
septic peritonitis | 11 |
poor response | 11 |
electrolyte imbalances | 11 |
transforming growth | 11 |
maternal antibodies | 11 |
similar clinical | 11 |
gastric decontamination | 11 |
maternal antibody | 11 |
mandibular lymph | 11 |
diseased dogs | 11 |
extravascular hemolysis | 11 |
preliminary data | 11 |
combination therapy | 11 |
fluid loss | 11 |
renal biopsy | 11 |
bacterial translocation | 11 |
examination revealed | 11 |
inflammatory lesions | 11 |
home range | 11 |
atrioventricular block | 11 |
infectious bronchiolitis | 11 |
mr imaging | 11 |
laboratory testing | 11 |
normal blood | 11 |
thyroid gland | 11 |
splenic contraction | 11 |
skin biopsy | 11 |
hematogenous spread | 11 |
prednisone therapy | 11 |
pcr products | 11 |
normal limits | 11 |
bacterial cultures | 11 |
lymphoid leukemia | 11 |
lymphoblastic leukemia | 11 |
pulmonary arteries | 11 |
iya project | 11 |
adult dog | 11 |
dogs use | 11 |
signed rank | 11 |
vaccination coverage | 11 |
lg kg | 11 |
usually associated | 11 |
per minute | 11 |
sinonasal aspergillosis | 11 |
clinical use | 11 |
peripheral lymphadenopathy | 11 |
exotic animals | 11 |
received financial | 11 |
treatment period | 11 |
topical application | 11 |
household dogs | 11 |
patients may | 11 |
therapeutic targets | 11 |
spayed female | 11 |
wildlife rabies | 11 |
felv antigenemic | 11 |
pancreatic inflammation | 11 |
cell origin | 11 |
faecalibacterium spp | 11 |
cobalamin supplementation | 11 |
may arise | 11 |
growth hormone | 11 |
intestinal mucosal | 11 |
ingestion includes | 11 |
mediated diseases | 11 |
clinical history | 11 |
thrombocytopenia may | 11 |
incidental finding | 11 |
thoracic radiograph | 11 |
albumin concentration | 11 |
cardiopulmonary arrest | 11 |
acute megakaryoblastic | 11 |
respiratory viruses | 11 |
remained unchanged | 11 |
status epilepticus | 11 |
toxocara canis | 11 |
disease characterized | 11 |
findings indicate | 11 |
chain variable | 11 |
cdv strains | 11 |
flow velocity | 11 |
many dogs | 11 |
operating characteristic | 11 |
motor neuron | 11 |
occurring canine | 11 |
eye may | 11 |
cerebral cortex | 11 |
aortic root | 11 |
will also | 11 |
ionized calcium | 11 |
superficial skin | 11 |
biliary system | 11 |
ascitic fluid | 11 |
electrolyte status | 11 |
rbc count | 11 |
parasite burden | 11 |
hydrostatic pressure | 11 |
contrast cystography | 11 |
normally distributed | 11 |
using different | 11 |
cutaneous plasmacytomas | 11 |
intermediate hosts | 11 |
canine cp | 11 |
circulating blood | 11 |
high performance | 11 |
small airway | 11 |
diffuse hepatic | 11 |
histologic changes | 11 |
free water | 11 |
anatomic forms | 11 |
include fever | 11 |
agents may | 11 |